Gastric intestinal metaplasia and early gastric cancer in the west: A changing paradigm

Gastroenterology and Hepatology

Volumn 10, Issue 6, 2014, Pages 369-378

  Gomez, Justin M ^a   Wang, Andrew Y ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Early gastric cancer; Endoscopic submucosal dissection; Esophagogastroduodenoscopy; Gastric intestinal metaplasia; Staging

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER STAGING; CHROMOENDOSCOPY; CLINICAL PRACTICE; EARLY CANCER; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; GASTRIC INTESTINE METAPLASIA; GASTRITIS; HUMAN; INTESTINE METAPLASIA; MAGNIFYING ENDOSCOPY; NARROW BAND IMAGING; PRACTICE GUIDELINE; PRECANCER; STOMACH CANCER; STOMACH LESION; UNITED STATES;

EID: 84904260038     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer. 1993;55(6):891-903. (Pubitemid 24005331)
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
3. International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality, and prevalence worldwide in 2012. http://globocan.iarc.fr. Accessed April 17, 2014.
4. Gotoda T. Endoscopic resection of early gastric cancer: the Japanese perspective. Curr Opin Gastroenterol. 2006;22(5):561-569. (Pubitemid 44197533)
5. Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89(11):2237-2246.
6. Schlemper RJ, Itabashi M, Kato Y, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet. 1997;349(9067):1725-1729. (Pubitemid 27252671)
7. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47(2):251-255. (Pubitemid 30489769)
8. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48(13):3554-3560.
9. De Luca A, Iaquinto G. Helicobacter pylori and gastric diseases: a dangerous association. Cancer Lett. 2004;213(1):1-10. (Pubitemid 39118528)
10. Genta RM. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol. 1996;20(suppl 1):S23-S30. (Pubitemid 26274912)
11. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161-1181.
12. Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010;31(10):1104-1111.
13. Filipe MI, Muñoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer. 1994;57(3):324-329. (Pubitemid 24168604)
14. Watanabe H. Intestinal metaplasia-the effect of acid on the gastric mucosa and gastric carcinogenesis. J Toxicol Pathol. 2010;23(3):115-123.
15. Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther. 2002;16(7):1209-1216.
16. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology. 2010;139(6):1894-1901. e2; quiz e12.
17. Gomez JM, Frye JW, Patrie JT, et al. The presence of gastric intestinal metaplasia in patients undergoing EGD with biopsy is associated with a family history of gastric cancer in the United States. J Gastroenterol Hepatol Res. 2013;2:479-482.
18. Rokkas T, Sechopoulos P, Pistiolas D, Margantinis G, Koukoulis G. Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis. Eur J Gastroenterol Hepatol. 2010;22(9):1128-1133.
19. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784-789.
20. de Vries AC, Kuipers EJ. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies. Helicobacter. 2007;12(suppl 2):22-31. (Pubitemid 350076223)
21. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125(6):1670-1677. (Pubitemid 37500431)
22. Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103(13):1049-1057.
23. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2006;4(5):566-572. (Pubitemid 44308164)
24. Tava F, Luinetti O, Ghigna MR, et al. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia. Hum Pathol. 2006;37(11):1489-1497. (Pubitemid 44584329)
25. Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol. 2010;105(3):493-498.
26. Hirota WK, Zuckerman MJ, Adler DG, et al; Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570-580.
27. Yagi K, Nakamura A, Sekine A. Intestinal metaplasia of gastric cardia and carditis in Japanese patients with Helicobacter pylori infection. Digestion. 2004;70(2):103-108. (Pubitemid 39370404)
28. Correa P. Chemoprevention of gastric cancer: has the time come? J Clin Oncol. 2003;21(23 suppl):270s-271s.
29. Matsukura N, Suzuki K, Kawachi T, et al. Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. J Natl Cancer Inst. 1980;65(2):231-240. (Pubitemid 10087412)
30. González CA, Pardo ML, Liso JM, et al. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Int J Cancer. 2010;127(11):2654-2660.
31. Wang J, Xu L, Shi R, et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion. 2011;83(4):253-260.
32. Dinis-Ribeiro M, Areia M, de Vries AC, et al; Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch. 2012;460(1):19-46.
33. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58(6 suppl):S3-S43.
34. Emura F, Gralnek I, Baron TH. Improving early detection of gastric cancer: a novel systematic alphanumeric-coded endoscopic approach. Rev Gastroenterol Peru. 2013;33(1):52-58.
35. Atkins L, Benedict EB. Correlation of gross gastroscopic findings with gastroscopic biopsy in gastritis. N Engl J Med. 1956;254(14):641-644.
36. Areia M, Amaro P, Dinis-Ribeiro M, et al. External validation of a classification for methylene blue magnification chromoendoscopy in premalignant gastric lesions. Gastrointest Endosc. 2008;67(7):1011-1018. (Pubitemid 351728107)
37. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, et al. Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastrointest Endosc. 2003;57(4):498-504. (Pubitemid 36402715)
38. Li HY, Dai J, Xue HB, et al. Application of magnifying endoscopy with narrow-band imaging in diagnosing gastric lesions: a prospective study. Gastrointest Endosc. 2012;76(6):1124-1132.
39. de Vries AC, Haringsma J, de Vries RA, et al. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter. 2010;15(4):259-264.
40. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077-3079.
41. Wang AY. The international emergence of endoscopic submucosal dissection for early gastric cancer. Gastrointest Endosc. 2011;73(5):928-931.
42. Roviello F, Rossi S, Marrelli D, et al. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol. 2006;94(4):275-280, discussion 274.
43. Yasuda K, Shiraishi N, Suematsu T, Yamaguchi K, Adachi Y, Kitano S. Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric carcinoma. Cancer. 1999;85(10):2119-2123. (Pubitemid 29215549)
44. Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3(4):219-225. (Pubitemid 32290729)
45. Seto Y, Nagawa H, Muto T. Impact of lymph node metastasis on survival with early gastric cancer. World J Surg. 1997;21(2):186-189, discussion 190.
46. Tsujitani S, Oka S, Saito H, et al. Less invasive surgery for early gastric cancer based on the low probability of lymph node metastasis. Surgery. 1999;125(2):148-154. (Pubitemid 29076108)
47. Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007;10(1):1-11. (Pubitemid 46356261)
48. Mocellin S, Marchet A, Nitti D. EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc. 2011;73(6):1122-1134.
49. Yoshida S, Tanaka S, Kunihiro K, et al. Diagnostic ability of high-frequency ultrasound probe sonography in staging early gastric cancer, especially for submucosal invasion. Abdom Imaging. 2005;30(5):518-523. (Pubitemid 41446668)
50. El Abiad R, Gerke H. Gastric cancer: endoscopic diagnosis and staging. Surg Oncol Clin N Am. 2012;21(1):1-19.
51. Okada K, Fujisaki J, Kasuga A, et al. Endoscopic ultrasonography is valuable for identifying early gastric cancers meeting expanded-indication criteria for endoscopic submucosal dissection. Surg Endosc. 2011;25(3):841-848.
52. Kim JH, Song KS, Youn YH, et al. Clinicopathologic factors influence accurate endosonographic assessment for early gastric cancer. Gastrointest Endosc. 2007;66(5):901-908. (Pubitemid 47600186)
53. Choi J, Kim SG, Im JP, Kim JS, Jung HC, Song IS. Endoscopic prediction of tumor invasion depth in early gastric cancer. Gastrointest Endosc. 2011;73(5):917-927.
54. Manner H, Rabenstein T, May A, et al. Long-term results of endoscopic resection in early gastric cancer: the Western experience. Am J Gastroenterol. 2009;104(3):566-573.
55. Horiki N, Omata F, Uemura M, et al. Risk for local recurrence of early gastric cancer treated with piecemeal endoscopic mucosal resection during a 10-year follow-up period. Surg Endosc. 2012;26(1):72-78.
56. Wang AY, Emura F, Oda I, Cox DG, Kim HS, Yeaton P. Endoscopic submucosal dissection with electrosurgical knives in a patient on aspirin therapy (with video). Gastrointest Endosc. 2010;72(5):1066-1071.
57. Oka S, Tanaka S, Kaneko I, et al. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc. 2006;64(6):877-883. (Pubitemid 44829827)
58. Oda I, Suzuki H, Nonaka S, Yoshinaga S. Complications of gastric endoscopic submucosal dissection. Dig Endosc. 2013;25(suppl 1):71-78.
59. Lee JH, Yom CK, Han HS. Comparison of long-term outcomes of laparoscopy-assisted and open distal gastrectomy for early gastric cancer. Surg Endosc. 2009;23(8):1759-1763.
60. Frye JW, Gomez JM, Bleibel W, Shami VM, Sauer BG, Wang AY. Lack of consensus regarding management of gastric intestinal metaplasia among practicing gastroenterologists indicates a need for societal guidelines. Gastrointest Endosc. 2013;77(5):AB261-AB262.
61. Frye JW, Sauer BG, Gomez JM, Shami VM, Northup PG, Wang AY. Gastroenterologists lack consensus regarding if, how, and when to screen or survey for premalignant gastric lesions: results of a pilot survey. Am J Gastroenterol. 2012;107(suppl 1s):S43-S44.